Search

Your search keyword '"Creuzot‐Garcher, Catherine"' showing total 1,365 results

Search Constraints

Start Over You searched for: Author "Creuzot‐Garcher, Catherine" Remove constraint Author: "Creuzot‐Garcher, Catherine"
1,365 results on '"Creuzot‐Garcher, Catherine"'

Search Results

2. Photocoagulation or sham laser in addition to conventional anti-VEGF therapy in macular edema associated with TelCaps due to diabetic macular edema or retinal vein occlusion (TalaDME): a study protocol for a multicentric, French, two-group, non-commercial, active-control, observer-masked, non-inferiority, randomized controlled clinical trial

5. DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration

14. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

15. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

16. Association of Systemic Medication Use with Glaucoma and Intraocular Pressure: The European Eye Epidemiology Consortium

18. A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

23. Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.

27. Myocardial infarction during giant cell arteritis: A cohort study

28. Mucosal-associated invariant T cells in Giant Cell Arteritis

30. Pros and cons of internal limiting membrane peeling during epiretinal membrane surgery: a randomised clinical trial with microperimetry (PEELING)

33. One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry

34. No association of endothelial lipase and aldose reductase polymorphisms with proliferative diabetic retinopathy: results of the French prospective multicenter REDIAGEN study

36. Cystoid maculopathy is a frequent feature of Cohen syndrome-associated retinopathy

38. Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia

39. Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion

40. Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina

41. European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice

42. Management of diabetic macular oedema in France from 2012 to 2018: The nationwide LANDSCAPE study.

43. Cataract surgical training in Europe: European Board of Ophthalmology survey

44. Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population

45. Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

46. The Decreasing Prevalence of Nonrefractive Visual Impairment in Older Europeans: A Meta-analysis of Published and Unpublished Data

47. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study)

50. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Catalog

Books, media, physical & digital resources